Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X


press

Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards

Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more


press
Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research
press
Mission Bio Tapestri Platform Identifies Novel Resistance Mechanisms with IDH Inhibitor TIBSOVO in Acute Myeloid Leukemias in Agios-led Study
press
Mission Bio and Agilent Technologies Enter into Co-Marketing Agreement to Expand Access to the Tapestri Platform for Single-Cell Multiomics
press
Leading Cancer Institutes Leverage Mission Bio’s Tapestri Platform to Reveal New Patterns of Evolution Underlying Leukemia Therapy Resistance
REQUEST QUOTE